TY - JOUR
T1 - Clinical Mycology Today
T2 - Emerging Challenges and Opportunities
AU - for the Mycoses Study Group Education & Research Consortium
AU - Little, Jessica
AU - Rauseo, Adriana M.
AU - Zuniga-Moya, Julio C.
AU - Spec, Andrej
AU - Pappas, Peter
AU - Perfect, John
AU - McCarthy, Todd
AU - Schwartz, Ilan S.
N1 - Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - The Mycoses Study Group Education and Research Consortium is a collective of clinicians, researchers, and educators with the common goal to advance awareness, diagnosis, and management of invasive fungal diseases. Clinical Mycology Today, the Mycoses Study Group Education and Research Consortium’s biennial meeting, is dedicated to discussing the most pressing contemporary issues facing the field of clinical mycology, promoting clinical, translational, and basic science collaborations, and mentoring the next generation of clinical mycologists. Here, we review the current opportunities and challenges facing the field of mycology that arose from discussions at the 2022 meeting, with emphasis on novel host risk factors, emerging resistant fungal pathogens, the evolving antifungal pipeline, and critical issues affecting the advancement of mycology research.
AB - The Mycoses Study Group Education and Research Consortium is a collective of clinicians, researchers, and educators with the common goal to advance awareness, diagnosis, and management of invasive fungal diseases. Clinical Mycology Today, the Mycoses Study Group Education and Research Consortium’s biennial meeting, is dedicated to discussing the most pressing contemporary issues facing the field of clinical mycology, promoting clinical, translational, and basic science collaborations, and mentoring the next generation of clinical mycologists. Here, we review the current opportunities and challenges facing the field of mycology that arose from discussions at the 2022 meeting, with emphasis on novel host risk factors, emerging resistant fungal pathogens, the evolving antifungal pipeline, and critical issues affecting the advancement of mycology research.
KW - AMR
KW - antifungals
KW - clinical trials
KW - diagnostics
KW - fungal infection
KW - mycoses
KW - mycosis
UR - http://www.scopus.com/inward/record.url?scp=85199456790&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofae363
DO - 10.1093/ofid/ofae363
M3 - Review article
C2 - 39045011
AN - SCOPUS:85199456790
SN - 2328-8957
VL - 11
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 7
M1 - ofae363
ER -